Deep search
Profile Picture
  • All
  • Search
  • Copilot
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Ann Wojcicki's TTAM to Acquire 23andMe for $305M

Fortune on MSN · 11h
Nonprofit run by former CEO Anne Wojcicki wins bid to acquire 23andMe
A nonprofit run by Anne Wojcicki, the cofounder and former CEO of 23andme, has agreed to buy the genetic testing company for $305 million. Wojcicki’s return is likely to spark lawsuits. The nonprofit,
CNN on MSN · 2d
Anne Wojcicki’s nonprofit wins bid to acquire genetic testing company 23andMe
The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.
CNBC on MSN · 15h
Former 23andMe CEO Anne Wojcicki wins bid for control of her former company, topping Regeneron
Anne Wojcicki, former chief executive of 23andMe, won a bid to acquire the genetic testing company she founded in a second auction.
6hon MSN
23andMe co-founder Anne Wojcicki regains control of bankrupt genetic testing company
Former 23andMe CEO Anne Wojcicki outbids Regeneron with a $305 million offer through her nonprofit TTAM to regain control of the DNA-testing company she co-founded.
4hon MSN
Regeneron declines to make higher bid for 23andMe after Wojcicki's $305 million offer
Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...
11h
Why is Anne Wojcicki regaining control of 23andMe and what it means for genomics firm
Anne Wojcicki is taking back reins of 23andMe after outbidding Regeneron. The entrepreneur's proposal offers better ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy